SR

Srinivasa Rao Nallagatla

Active Director Director DIN 07202081
DIN 07202081 First appointment Aug 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Aug 2015
Shareholding value •••• Premium profile

About Srinivasa Rao Nallagatla

Data last updated:

Srinivasa Rao Nallagatla is a Director at Xavier Med Private Limited (since 2018), Director at Lumens Medical Private Limited (since 2015) and Director at Lemuria-Ai Private Limited (since 2026), and holds 2 more current directorships. The companies operate in Healthcare, Musical Instruments and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹6.35 Cr; the largest is Xavier Med Private Limited at ₹5.43 Cr (FY 2025). Earlier, Srinivasa Rao Nallagatla was a Director at Mediserve Devices Private Limited (2020–2023).

DIN 07202081
Primary Designation Director
Industry Healthcare
First Appointment 22 Aug 2015
Oldest Company Age 11 yrs
Largest company Xavier Med Private Limited · ₹5.43 Cr (FY 2025)
Combined revenue ₹6.35 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Xavier Med Private Limited U33300TG2018PTC126019
Director06 Aug 20182018₹5.43 Cr (FY 2025)Active
Lumens Medical Private Limited U33111TG2015PTC100404
Director22 Aug 20152015₹92.4 Lakh (FY 2024)Active
Lemuria-Ai Private Limited U62011TS2026PTC218365
Director28 Jun 20262026Active
Synthex Naturals Private Limited U21003TS2023PTC179547
Director17 Dec 20242023Active
Arsino Projects Private Limited U33309TG2022PTC169205
Director13 Dec 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mediserve Devices Private Limited U33100DL2020PTC361860
Director14 Feb 20202020₹10.5 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lumens Medical Private Limited
Xavier Med Private Limited
Arsino Projects Private Limited
Synthex Naturals Private Limited
Premium access

Shareholding and investment profile for Srinivasa Rao Nallagatla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srinivasa Rao Nallagatla

Srinivasa Rao Nallagatla currently holds 5 directorships: Xavier Med Private Limited (Director, since 06 Aug 2018, revenue ₹5.43 Cr (FY 2025)); Lumens Medical Private Limited (Director, since 22 Aug 2015, revenue ₹92.4 Lakh (FY 2024)); Lemuria-Ai Private Limited (Director, since 28 Jun 2026); Synthex Naturals Private Limited (Director, since 17 Dec 2024); Arsino Projects Private Limited (Director, since 13 Dec 2022).

Srinivasa Rao Nallagatla was first appointed on 22 Aug 2015 as Director at Lumens Medical Private Limited. The most recent appointment on record is 28 Jun 2026 at Lemuria-Ai Private Limited.

The 2 current companies of Srinivasa Rao Nallagatla that report revenue have a combined latest revenue of ₹6.35 Cr: Xavier Med Private Limited ₹5.43 Cr (FY 2025); Lumens Medical Private Limited ₹92.4 Lakh (FY 2024).

Srinivasa Rao Nallagatla held 1 earlier board appointment: Mediserve Devices Private Limited (Director, 14 Feb 2020 to 11 Dec 2023).

The current boards of Srinivasa Rao Nallagatla's companies include Kaushik Nagaraju (Xavier Med Private Limited), Nagaraju Usha Rani (Xavier Med Private Limited), Shwetha Nallagatla (Lumens Medical Private Limited), Archana Pandit (Lemuria-Ai Private Limited), Rajeev Mohan Sood (Lemuria-Ai Private Limited), Sudish Kumar Mogli (Lemuria-Ai Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available